Statements (31)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:chemical_compound
gptkb:drug |
gptkbp:approvalYear |
2022
|
gptkbp:approvedBy |
gptkb:FDA
|
gptkbp:ATCCode |
D05AX30
|
gptkbp:brand |
Vtama
|
gptkbp:CASNumber |
29700-22-9
|
gptkbp:developer |
gptkb:Dermavant_Sciences
|
gptkbp:drugClass |
immunotherapy
|
gptkbp:firstBook |
yes
|
gptkbp:form |
gptkb:butter
|
gptkbp:hasMolecularFormula |
C17H18O3
|
gptkbp:hasSMILES |
CC1=CC(=C(C=C1)O)C2=CC(=C(C=C2)O)C(C)C=O
|
https://www.w3.org/2000/01/rdf-schema#label |
tapinarof
|
gptkbp:legalStatus |
prescription only
|
gptkbp:mechanismOfAction |
aryl hydrocarbon receptor agonist
|
gptkbp:pregnancyCategory |
Not assigned
|
gptkbp:prescriptionStatus |
Rx only
|
gptkbp:PubChem_CID |
CHEMBL2103887
32699413 54685836 |
gptkbp:routeOfAdministration |
topical
|
gptkbp:sideEffect |
gptkb:contact_dermatitis
gptkb:folliculitis headache pruritus upper respiratory tract infection |
gptkbp:UNII |
6T1I0UT04D
|
gptkbp:usedFor |
plaque psoriasis
|
gptkbp:bfsParent |
gptkb:VTAMA_cream
|
gptkbp:bfsLayer |
7
|